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‚ Performance estimates for individual doctors are unreliable due to small samples [11 
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Should interventions to reduce variation in care quality 
target doctors or hospitals? 
Abstract 
Interventions to reduce variation in care quality are increasingly targeted at both individual doctors 
and the organisations in which they work. Concerns remain about the scope and consequences for 
such performance management, the relative contribution of individuals and organisations to 
observed variation, and whether performance can be measured reliably.  
This study explores these issues in the context of the English National Health Service by analysing 
comprehensive administrative data for all patients treated for four clinical conditions (acute 
myocardial infarction, hip fracture, pneumonia, ischemic stroke) and two surgical procedures 
(coronary artery bypass, hip replacement) during April 2010 to February 2013. Performance 
indicators (PIs) are defined as 30-day mortality, 28-day emergency readmission and inpatient length 
of stay. Three-level hierarchical generalised linear mixed models are estimated to attribute variation 
in case-mix adjusted indicators to individual doctors and hospital organisations.  
Except for length of stay after hip replacement, no more than 11% of variation in case-mix adjusted 
PIs can be attributed to doctors and organisations with the rest reflecting random chance and 
unobserved patient factors. Doctor variation exceeds hospital variation by a factor of 1.2 or more. 
However, identifying poor performance amongst doctors is hampered by insufficient numbers of 
cases per doctor to reliably estimate their individual performances. Policy makers and regulators 
should therefore be cautious when targeting individual doctors in performance improvement 
initiatives. 
1 Introduction 
Large variations in the quality of health care have been reported over many years, and in many 
countries [1, 2]. Policymakers and professional bodies have responded to such variations with a 
variety of mechanisms including measurement  ? ?ƉƌŽĨŝůŝŶŐ ? ?, monitoring, public reporting, regulation 
and incentives (financial and non-financial) [3, 4]. These interventions have mostly been focused on 
organisational performance, particularly at the level of the hospital or clinical specialty, with the 
implicit assumption that the variation results from factors that can be influenced or affected by 
organisations and those who lead them.  
Increasingly, interventions to improve care quality and reduce variations operate not just at 
organisational level but at the level of individual doctors. For example, a number of initiatives have 
been introduced with the aim of improving hospital specialists ?mortality rates through 
measurement, public reporting and feedback, most notably in cardiac surgery in the UK and US [5, 
6]. In the National Health Service (NHS) in England, this has been extended to routine publication of 
outcome data for  consultants (fully-trained hospital specialists) working in 13 specialities [7, 8].  
Despite substantial investments in these mechanisms intended to drive improvements in the quality 
of care, considerable uncertainty exists about whether individual consultants or the organisations in 
*Manuscript (without Author Details)
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which they work are more important as drivers of variation in the quality of health care. The utility 
of information derived from administrative data for individual or organisational performance 
management purposes, and the potential for unintended consequences, remain poorly understood. 
For example, there is only limited UK evidence on the degree of performance variation among 
doctors for outcomes other than mortality [9]. In addition, the assessment of performance of 
individual consultants raises a statistical concern: estimates of their performance are more 
vulnerable to chance events than those of hospitals because they are based on smaller patient 
populations [10]. A number of studies have suggested that using indicators at individual level may 
result in often unreliable estimates of true performance [11-15]. Unreliable estimates may result in 
ŝŶĐŽƌƌĞĐƚĚĞĐŝƐŝŽŶƐĂďŽƵƚĚŽĐƚŽƌƐ ?performance with potentially adverse consequences for individual 
careers, the welfare of patients, and the credibility of the measurement process.  
This paper explores these issues in the context of the English NHS, extending a previous analysis of 
mortality variation in England [14] and also focusing on two performance indicators (PIs) not 
previously analysed: emergency re-admission within 28 days of discharge and inpatient length of 
stay. The analysis seeks to answer two questions. First, how much variation in observed PIs can be 
attributed to individual hospital consultants and how does this compare with that attributable to the 
organisations in which they work? Second, are performance estimates for individual consultants 
sufficiently reliable to be useful estimates of their true performance? 
2 Methods 
2.1 Study population 
We used data from Hospital Episode Statistics (HES) on all NHS-funded inpatient care provided in 
hospitals in England between April 2010 and February 2013. We focused on six 
conditions/procedures that were selected because they are based on validated indicators used 
internationally [16, 17], they cover a range of clinical areas and are either part of the consultant-
level reporting initiative in England [8] or constitute a substantial proportion of NHS activity: 
emergency admissions for treatment of acute myocardial infarction (AMI), acute ischemic stroke 
(AIS), pneumonia and hip fracture; and elective admissions for unilateral primary (i.e. non-revision) 
hip replacement and isolated coronary artery bypass graft (CABG) surgery. These groups were 
constructed following US Agency for Healthcare Research and Quality ?Ɛ inpatient quality indicator 
(IQI) definitions (IQI#12, #14, #15, #17, #19, #20), which were recently amended for use with English 
NHS data as part of a European study of health care variations [16]. A full list of relevant ICD-10 
diagnosis codes and OPCS-4 procedure codes are reported in the Appendix. Patients were excluded 
if they were younger than 18 years at the time of admission (<40 years for CABG surgery; <65 for hip 
fracture) or were living outside of England. 
HES records inpatient activity at the level of Finished Consultant Episodes (FCEs), which we linked to 
create continuous inpatient spells that cover the entire period from admission to discharge 
(including transfers between hospitals). Data were extracted on all inpatient activity 365 days before 
index admission and 28 days after discharge (up to 31
st
 March 2013). Record linkage was based on 
unique NHS identification numbers. Admission spells were assigned to the first consultant 
responsible for treatment after the index admission. Consultants who provided care in different 
hospital organisations were treated as separate units of observation. This issue was most prevalent 
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in elective hip replacement surgery, where consultants often work both in NHS hospital trusts and 
privately operated Independent Sector Treatment Centres. Consultants were identified through their 
unique General Medical Council (GMC) code. These codes were validated against the GMC database 
of registered specialists and the Electronic Staff Record system and invalid records were excluded 
from analysis. Consultants (and their patients) were excluded if they treated less than 30 cases over 
the three-year period. Similarly, hospitals were excluded if they treated less than 90 cases over this 
period. 
2.2 Performance indicators 
We investigated variation in important clinical outcomes and process of care measures that are 
commonly used as PIs. The clinical outcomes were 28-day all-cause emergency readmission and 30-
day all-cause mortality, which was derived from Office for National Statistics date of death data. 
Length of inpatient stay, measured as the number of overnight stays, was used to approximate the 
effectiveness of discharge management processes. To reduce the influence of potential miscoding 
values exceeding the 99
th
 percentile of the distribution of length of stay were replaced with the 99
th
 
percentile.  
2.3 Case-mix adjustment  
All PIs were adjusted for age (5-year bands with separate categories for <25 and >=85; except in the 
analysis of mortality in which lowest category is <60), sex, age-sex interactions and year of 
hospitalisation. Severity adjustment was limited to information contained in administrative records 
and included an indicator for any hospital emergency admission in the previous year, as well as the 
number of Elixhauser co-morbid conditions (grouped as 0, 1, 2-3, 4+) recorded in secondary 
diagnosis fields in the index admission or admissions in the previous year ?WĂƚŝĞŶƚƐ ?ƐŽĐŝŽ-economic 
status was approximated by the proportion of residents at small area level (Lower Super Output 
Area; approximately average population of 1,500 inhabitants) claiming means-tested social security 
benefits (divided into five quintile groups) [18].  
2.4 Statistical analysis 
Three-level hierarchical generalised linear mixed models were fitted to identify variation in PIs due 
to provider case-mix, additional systematic variation associated with consultants and hospital 
organisations, and random chance variation [19, 20]. Patient episodes are nested in consultants, 
which are themselves nested in hospitals. Emergency readmissions and mortality were modelled 
using logistic regression. Length of stay was modelled as count data using Poisson models with an 
additional over-dispersion parameter. Separate models were estimated for each patient group and 
PI. Data were pooled across three years to reflect common practice in performance assessment 
schemes [14].  
The fixed part of the model captures variation in PIs associated with observable differences in 
provider case-mix (see section 2.3). The model error term captures the variation in the PI that is not 
explained by observed patient characteristics and is further partitioned into separate components 
varying at patient level (i.e. unmeasured patient characteristics or random noise with variance ߪଶ), 
consultant level (߬ଶ) and hospital level (߱ଶ). From that we calculated variance partition coefficients 
(VPC) at the response scale by means of simulation [21, 22]. Each VPC measures the proportion of 
unexplained variation in PIs associated with the respective level of the hierarchy. For example, the 
VPC at consultant level is defined as 
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ܸܲܥ௖௢௡௦௨௟௧௔௡௧ ൌ ߬ଶߪଶ ൅ ߬ଶ ൅ ߱ଶ 
and similarly for other levels. By design, all VPCs must sum to unity. Higher values of VPC therefore 
indicate a larger influence on PIs relative to other levels.  
In most performance assessment schemes, case-mix adjusted performance estimates are obtained 
by means of indirect standardisation. There is a risk that any performance estimates for individual 
consultants conflate true variation across consultants with random noise. The reliability (R) of 
performance estimates for individual consultants is a function of their case-load ܰ and the ܸܲܥ௖௢௡௦௨௟௧௔௡௧. It is calculated as ܴ௖௢௡௦௨௟௧௔௡௧ ൌ  ܰ ൈ ܸܲܥ ? ൅ ሾܰ െ  ?ሿ ൈ ܸܲܥ 
with  ? ൏ ܴ ൑  ? [10]. Higher values of R indicate that ĞƐƚŝŵĂƚĞƐŽĨŝŶĚŝǀŝĚƵĂůĐŽŶƐƵůƚĂŶƚƐ ?
performance are less subject to unrelated variation and are thus more suitable for performance 
assessment purposes. Values of ൒0.7 are often required for low-stakes applications such as 
confidential reports to clinicians with limited risk of punitive actions [15]. Conversely, values of ൒0.9 
have been suggested for high-stakes applications such as public reporting of performance or pay-for-
performance schemes. The minimum level of activity required for a given level of reliability R can be 
obtained by solving the above equation for ܰ. We calculated minimum activity thresholds and the 
proportion of consultants fulfilling these thresholds to achieve reliability of 0.7 and 0.9, respectively. 
All statistical analyses were performed in Stata 13 (StataCorp LP, College Station, TX, USA) and 
MLwiN 2.36 (Centre for Multilevel Modelling, University of Bristol, UK). 
3 Results 
A total of 1,211,983 patients were included in the initial sample. Of these, 172,826 (14.3%) patients 
did not fulfil the inclusion criteria, leaving 1,039,157 patients for further analysis (Table 1). These 
patients received care from 7,197 consultants (6,731 unique GMC codes) in 240 hospitals. The 
number of patients per consultant varied substantially within and across conditions. The lowest 
case-load was observed for consultants treating AIS patients (median=55; IQR=38-150) and the 
highest consultant case-load was for CABG surgery (median=104; IQR=72-158).  
[Table 1 here] 
Patients in our sample were on average 73 years old and approximately half were male. The overall 
28-day emergency readmission and 30-day mortality rates were 12.0% and 11.0% respectively, and 
patients stayed in hospital for 12.5 nights on average. There was marked variation in patient 
characteristics and PIs across conditions. Patients admitted for planned care were on average 
younger (68 vs. 75 years), stayed shorter in hospital (5.8 vs. 14.1 nights) and were at lower risk of 
readmission (6.2 % vs. 13.4%) and mortality (0.2% vs 13.5%). 
3.1 Variation across hospitals and consultants 
All coefficients on case-mix variables show the expected sign and internally consistent ranking of 
magnitudes. The McKelvey-Zavoina Pseudo R
2
 statistics [10, 23, 24] measure the proportion of 
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variance in PIs explained by observed patient characteristics and range from 16.7% to 26.9% for 
mortality, 2.7% to 4.4% for emergency readmission, and 5.7% to 22.8% for the number of inpatient 
days. More detail on regression coefficients and explained variance are provided in the Appendix. 
Our primary interest is in the proportion of variation not explained by case-mix and how this relates 
to consultants and hospital organisations. Figure 1 shows the estimated VPCs at consultant and 
hospital level (stacked) for each of the three PIs and by condition. Approximately 0.6% to 4.1% of 
unexplained variation in the case-mix adjusted probability of readmission can be attributed to 
hospitals and consultants. The remainder reflects random variation at patient level that is not 
associated with observed patient characteristics. VPCs for mortality are of similar magnitude and 
range from 0.3% to 2.0%. Conversely, hospitals and consultants have a relatively larger influence 
ŽǀĞƌƉĂƚŝĞŶƚƐ ?ůĞŶŐƚŚŽĨƐƚĂǇ ?ĞƚǁĞĞŶ1.9% and 22.6% of unexplained variation in length of stay is 
associated with either consultant or hospital. Note that the noticeably larger variation in length of 
stay after planned hip replacement surgery may reflect differences in the performance of public and 
private hospitals [25];  with hip replacement being the only condition studied for which this 
distinction is relevant. 
The proportion of unexplained variation at consultant level exceeds that at hospital level by a factor 
of 1.2 or more, except for emergency readmission after AMI.  It was not possible to differentiate 
consultant and hospital variation for mortality after planned hip replacement surgery as part of the 
estimation procedure, and the presented number should therefore be interpreted as a composite. 
[Figure 1 about here] 
3.2 Reliability of consultant and hospital performance estimates 
Table 2 shows the reliability of consultant performance estimates for the three PIs, the level of 
activity required to achieve reliability of at least 0.7 and 0.9, and the proportion of consultants that 
fulfil this requirement. The reliability of consultantƐ ? emergency readmission rates as indicators of 
their performance ranges from 0.19 to 0.71. The required 3-year activity to achieve a reliability of 
ш ? ? ?lies between 92 to 563 admissions for the six conditions studied. Very few consultants achieve 
such case-loads. By extension, even fewer consultants reach case-loads required for a reliability of 
ш ? ? ? ?A noteworthy exception is hip replacement surgery, where more than half of consultants treat 
ĂƐƵĨĨŝĐŝĞŶƚŶƵŵďĞƌŽĨƉĂƚŝĞŶƚƐƚŽŽďƚĂŝŶƌĞůŝĂďůĞĞƐƚŝŵĂƚĞƐĂƚƌш ? ? ? ?
Estimates of reliability and required case-load for 30-day mortality follow the same pattern. 
[Table 2 here] 
The reliability of consultant performance estimates for length of stay is significantly higher. At 
median activity level, the reliability is estimated to range from 0.46 to 0.93. For each of the six 
conditions studied, at least 25% of consultants treat enough patients to achieve a reliability of at 
least 0.7. In some cases, such as cardiac surgeons performing CABG surgery, this is true for more 
than 90% of consultants. Between 0.4% and 70% of consultants achieve a reliability of 0.9 or more. 
Table 3 reports the same information for hospital performance estimates. As hospital organisations 
are usually held accountable for all variation that is not attributable to case-mix and random noise, 
including variation that derives from consultants working for them, the reported estimates are 
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based on the pooled VPC, calculated as ܸܲܥ஼௢௡௦௨௟௧௔௡௧ ൅ ܸܲܥு௢௦௣௜௧௔௟. Unsurprisingly, performance 
estimates at hospital level are significantly more reliable than those calculated for consultants due to 
the substantially larger case-loads and the increased VPC. The reliability of performance estimates 
for a hospital of median activity levels exceeded 0.85 for all indicators and conditions. A large share 
of hospitals fulfils volume requirements to achieve reliability of 0.9, ranging from 29% of hospitals 
for emergency readmission after AMI to 100% for length of stay after bypass surgery.  
4 Discussion 
This study demonstrated that for the performance indicators and conditions chosen, the amount of 
case-mix adjusted variation that is attributable to consultants generally exceeds that which is 
attributable to organisations, although both are substantially outweighed by random variation at 
patient level that is not explained by the observed patient characteristics. In addition, we found that 
a large proportion of consultants do not treat a sufficient volume of patients for performance 
estimates based on these measures to represent reliably their underlying performance.  
Commentators have considered the estimated proportion of variability in performance indicators at 
levels higher than patients (including physicians, groups and organisations) as low or even trivial and 
have raised concerns about the purpose of performance management [26]. However, we wish to 
stress that such judgements must consider not only the amount of unwarranted variation but also 
the value of the performance indicators and the direct and indirect costs of initiatives aimed at 
eradicating it [27]. For example, assuming an average cost of an emergency readmission in the 
English NHS of £2,100 [28], we estimate the overall value of improving consultant performance to 
match that of the current average for our sample alone to be approximately £8.4 million. This 
ignores any patient health benefits associated with a reduced risk of readmissions. The organisations 
in which consultants work also play a role in determining outcomes, albeit less than consultants. 
Hence, the possible benefit of reducing unwarranted variation between consultants and/or 
organisations is unlikely to be negligible, although this does not necessarily imply that any such 
effort is a cost-effective use of resources. 
As the amount of case-mix adjusted variation between consultants generally exceeds that which 
occurs between ŽƌŐĂŶŝƐĂƚŝŽŶƐ ?ĂĨŽĐƵƐŽŶŝŶĚŝǀŝĚƵĂůĚŽĐƚŽƌƐ ?ƉĞƌĨŽƌŵĂŶĐĞŵĂǇďĞƚŚŽƵŐŚƚũƵƐƚŝĨŝĞĚ ?
In practice, however, there are obstacles to realising the potential benefit of consultant-level 
performance information. In particular, efforts to identify poorly performing consultants using 
outcome measures such as readmission and mortality derived from routine data are likely to 
encounter measurement problems: a large proportion of consultants do not treat a sufficient 
number of patients over a three-year period for these performance estimates to be reliable 
representations of their individual underlying performances. There are several ways in which the 
reliability of individual performance estimates can be improved, although each comes with their 
own problems. Firstly, most consultants provide a variety of treatments for different patient groups 
and this can be exploited to generate more comprehensive performance profiles on larger, and thus 
more reliable, patient samples [29]. This, however, requires a more complex case-mix adjustment 
strategy and may hide differential performances among the components of the composite for 
individual consultants [30]. An alternative approach is to employ shrinkage estimators, which take 
into account reliability to generate estimates that are less subject to random variation and 
regression-to-the-mean [31, 32]. This means, however, that resulting estimates of consultant 
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performance are overly conservative and biased towards the average [33]. The implication is that 
poorly performing consultants with smaller caseloads would be less likely to be identified correctly 
as negative outliers.  
These results suggest that policymakers seeking to manage performance and reduce unwarranted 
variation pursue the right target but do so by the wrong means. While the variation across 
consultants overall is larger than between hospitals, the performance of an individual consultant is 
difficult to establish reliably. This suggests that performance management approaches seeking to 
leverage routinely collected data on ŝŶĚŝǀŝĚƵĂůĐŽŶƐƵůƚĂŶƚƐ ?ƉĞƌĨŽƌŵĂŶĐĞs risk generating a non-
trivial number of false positive warnings, which may undermine trust in the validity and fairness of 
the assessment. Until methods ƚŽŝŶĐƌĞĂƐĞƚŚĞƌĞůŝĂďŝůŝƚǇŽĨŝŶĚŝǀŝĚƵĂůĐŽŶƐƵůƚĂŶƚƐ ?ƉĞƌĨŽƌŵĂŶĐĞ
estimates have been agreed and implemented, approaches to performance management may be 
best aimed at the entire population of consultants (e.g. through enhanced professional regulation) 
rather than a subset identified by unreliable means.  
There are a number of limitations to our study. First, in line with current UK health policy we have 
chosen consultants (fully trained hospital specialists) as the unit of analysis. However, consultants 
generally lead teams of healthcare professionals and we cannot observe the actions taken by each 
individual. It may therefore not be the consultant that had a measurable effect on outcomes; 
although some may argue that, as leaders of these teams, they remain ultimately responsible. 
Second, as in all observational studies, our results may be subject to unobserved confounding. Most 
importantly, length of stay and emergency readmission may be determined by local supply factors, 
such as the availability of primary care services or care home places. This may explain some of the 
variation observed across hospitals but is unlikely to explain variation between consultants within 
the same hospital. Thus, consultant-level variance partition coefficients and the reliability of 
individual performance estimates may be underestimated. Similarly, performance estimates may be 
biased by unobserved differences in case-mix. If, for example, more severely ill patients are more 
likely to seek treatment from providers offering reportedly better services then the estimated 
variation in performance would be biased downwards. This is clearly of less concern for emergency 
care where patients have limited ability to choose and so may affect estimates differently across 
conditions. Third, variation among healthcare providers in dichotomous outcomes (mortality, 
readmission) may be more difficult to estimate than in continuous outcomes (length of stay) for a 
given sample size. Since the probability of mortality and readmission, rather than the actual event, 
can never be observed, this constitutes an inherent limitation of these metrics. Fourth, we have 
focussed on a number of high-volume procedures and conditions that form part of performance 
assessment initiatives in England or elsewhere and for which validated performance indicators exist. 
But these conditions necessarily capture only a subset of all inpatient activity in English hospitals and 
it is, therefore, unclear in how far our results can be generalised to other patient populations. 
Finally, while our analysis provides estimates of the degree of variation in patient outcomes and 
length of inpatient stay that is associated with consultants and hospitals it was not designed to 
identify the influences and decisions that result in this variation. For example, some of the observed 
variation at hospital level may be due to differences in infrastructure, which may be difficult to 
resolve in the short run or is outside the control of the organisation entirely. 
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5 Conclusions 
Policy makers, healthcare regulators and professional bodies in the UK and elsewhere are 
increasingly targeting both organisations and individual hospital consultants through a variety of 
performance management schemes and mechanisms. Our study shows that consultants vary in 
terms of their clinical outcomes and resource utilisation, and that in general the proportion of 
unexplained variation at consultant level exceeds that at hospital level. However, both consultant 
and hospital factors explain only a small fraction of the variation in risk-adjusted patient outcomes 
and process measures (length of stay, mortality and readmissions) compared with unmeasured 
patient characteristics and random noise, which seems to suggest that the potential impact of these 
performance management schemes aimed at organisations, individual consultants or both is likely to 
be relatively limited. In addition, relatively small patient samples per consultant make it difficult to 
form reliable judgements about ĐŽŶƐƵůƚĂŶƚƐ ?individual performance, and suggest that producing 
and publishing such comparisons may be at best uninformative and at worst misleading. 
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Appendix 1: Sample definition ʹ diagnosis and procedure codes 
Sample ICD-10 diagnosis codes OPCS4 procedure codes 
AMI I21 - I22 - 
CABG - 
K40 - K46  
Exclusion: K35 - K38, K49 - 
K50 
Hip fracture S72.0 - S72.2, S72.9 - 
Hip replacement - 
W37 - W39, W46 - W48, W52 
- W54, W58.1, W93 - W95 
Exclusion: Z94.1 + Z94.2, 
Z94.3 or any code indicating 
revision surgery 
Stroke H34.1, I63 - I64 - 
Pneumonia J12 - J18 - 
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Appendix 2: Odds ratios (ORs) and 95% confidence intervals (CIs) ʹ 28-day emergency readmission 
  AMI   CABG   Hip fracture   Hip replacement   Pneumonia   Stroke 
Variable OR 95%CI   OR 95%CI   OR 95%CI   OR 95%CI   OR 95%CI   OR 95%CI 
Age: <25 1.13 (0.24 - 5.21)         0.66 (0.24 - 1.83)   0.69 (0.37 - 1.28)   0.99 (0.87 - 1.14)   2.15 (1.31 - 3.54) 
Age: 25-29 1.73 (0.72 - 4.16) 
    
0.25 (0.06 - 1.02) 
 
0.35 (0.16 - 0.75) 
 
0.92 (0.80 - 1.06) 
 
0.59 (0.27 - 1.27) 
Age: 30-34 1.09 (0.63 - 1.89) 
    
0.74 (0.32 - 1.71) 
 
0.50 (0.30 - 0.82) 
 
0.95 (0.84 - 1.08) 
 
1.00 (0.62 - 1.61) 
Age: 35-39 1.40 (1.03 - 1.89) 
    
0.42 (0.19 - 0.90) 
 
0.47 (0.32 - 0.70) 
 
1.00 (0.89 - 1.12) 
 
1.34 (0.97 - 1.85) 
Age: 40-44 1.21 (1.00 - 1.47) 
 
1.70 (0.61 - 4.75)
 
0.84 (0.55 - 1.30) 
 
0.49 (0.37 - 0.66) 
 
1.03 (0.94 - 1.14) 
 
1.30 (1.04 - 1.64) 
Age: 45-49 1.08 (0.93 - 1.25) 
 
0.62 (0.24 - 1.59) 
 
0.57 (0.41 - 0.80) 
 
0.46 (0.36 - 0.57) 
 
1.12 (1.02 - 1.22) 
 
1.14 (0.94 - 1.38) 
Age: 50-54 0.98 (0.86 - 1.12) 
 
0.63 (0.26 - 1.51) 
 
0.58 (0.45 - 0.73) 
 
0.52 (0.44 - 0.61) 
 
1.00 (0.92 - 1.08) 
 
1.17 (1.00 - 1.38) 
Age: 55-59 0.89 (0.79 - 1.00) 
 
0.63 (0.27 - 1.47) 
 
0.56 (0.46 - 0.67) 
 
0.44 (0.38 - 0.52) 
 
1.13 (1.05 - 1.21) 
 
1.04 (0.89 - 1.21) 
Age: 60-64 0.93 (0.84 - 1.03) 
 
0.66 (0.29 - 1.51) 
 
0.57 (0.50 - 0.66) 
 
0.49 (0.43 - 0.55) 
 
1.16 (1.09 - 1.23) 
 
1.18 (1.05 - 1.33) 
Age: 65-69 0.96 (0.87 - 1.05) 
 
0.70 (0.31 - 1.58) 
 
0.76 (0.68 - 0.84) 
 
0.50 (0.44 - 0.56) 
 
1.20 (1.14 - 1.26) 
 
0.99 (0.89 - 1.10) 
Age: 70-74 0.93 (0.86 - 1.02) 
 
0.73 (0.32 - 1.62) 
 
0.79 (0.73 - 0.85) 
 
0.55 (0.49 - 0.62) 
 
1.28 (1.23 - 1.35) 
 
1.06 (0.97 - 1.15) 
Age: 75-79 0.99 (0.91 - 1.06) 
 
0.74 (0.33 - 1.65) 
 
0.83 (0.78 - 0.87) 
 
0.68 (0.61 - 0.76) 
 
1.17 (1.12 - 1.22) 
 
1.10 (1.02 - 1.18) 
Age: 80-84 0.98 (0.91 - 1.05) 
 
0.77 (0.33 - 1.78) 
 
0.94 (0.89 - 0.98) 
 
0.82 (0.73 - 0.92) 
 
1.10 (1.06 - 1.14) 
 
1.08 (1.01 - 1.16) 
Age: 85+ (excluded) 1.00 (1.00 - 1.00) 
 
1.00 (1.00 - 1.00) 
 
1.00 (1.00 - 1.00) 
 
1.00 (1.00 - 1.00) 
 
1.00 (1.00 - 1.00) 
 
1.00 (1.00 - 1.00) 
Age: <25 * male 1.23 (0.23 - 6.69) 
    
0.50 (0.14 - 1.73) 
 
0.75 (0.29 - 1.93) 
 
0.92 (0.76 - 1.12) 
 
0.85 (0.39 - 1.84) 
Age: 25-29 * male 0.34 (0.11 - 1.02) 
    
1.42 (0.30 - 6.82) 
 
1.82 (0.69 - 4.77) 
 
1.17 (0.96 - 1.43) 
 
2.69 (1.08 - 6.71) 
Age: 30-34 * male 1.18 (0.64 - 2.18) 
    
0.84 (0.32 - 2.20) 
 
1.55 (0.81 - 2.96) 
 
1.10 (0.92 - 1.31) 
 
1.01 (0.53 - 1.94) 
Age: 35-39 * male 0.64 (0.45 - 0.90) 
    
1.09 (0.44 - 2.70) 
 
1.20 (0.72 - 2.02) 
 
0.98 (0.84 - 1.15) 
 
0.98 (0.63 - 1.51) 
Age: 40-44 * male 0.65 (0.52 - 0.81) 
 
0.33 (0.16 - 0.71)
 
0.94 (0.56 - 1.58) 
 
1.30 (0.91 - 1.86) 
 
1.10 (0.96 - 1.25) 
 
0.88 (0.64 - 1.19) 
Age: 45-49 * male 0.76 (0.65 - 0.90) 
 
0.79 (0.44 - 1.41) 
 
1.22 (0.80 - 1.86) 
 
1.20 (0.91 - 1.59) 
 
1.10 (0.98 - 1.24) 
 
0.89 (0.69 - 1.13) 
Age: 50-54 * male 0.76 (0.66 - 0.88) 
 
0.88 (0.58 - 1.35) 
 
1.06 (0.75 - 1.49) 
 
1.16 (0.95 - 1.42) 
 
1.17 (1.05 - 1.30) 
 
0.92 (0.76 - 1.12) 
Age: 55-59 * male 0.83 (0.73 - 0.95) 
 
0.81 (0.58 - 1.14) 
 
1.43 (1.09 - 1.87) 
 
1.23 (1.03 - 1.46) 
 
1.05 (0.96 - 1.15) 
 
0.93 (0.77 - 1.11) 
Age: 60-64 * male 0.73 (0.66 - 0.82) 
 
0.81 (0.61 - 1.06) 
 
1.56 (1.28 - 1.90) 
 
1.19 (1.05 - 1.36) 
 
1.09 (1.01 - 1.17) 
 
0.84 (0.73 - 0.97) 
Age: 65-69 * male 0.80 (0.72 - 0.88) 
 
0.75 (0.60 - 0.95) 
 
1.08 (0.92 - 1.26) 
 
1.39 (1.24 - 1.56) 
 
1.07 (1.01 - 1.14) 
 
1.02 (0.90 - 1.15) 
Age: 70-74 * male 0.86 (0.79 - 0.94) 
 
0.79 (0.64 - 0.98) 
 
1.10 (0.97 - 1.25) 
 
1.31 (1.18 - 1.45) 
 
1.01 (0.95 - 1.06) 
 
1.03 (0.93 - 1.14) 
Age: 75-79 * male 0.89 (0.82 - 0.97) 
 
0.94 (0.75 - 1.17) 
 
1.29 (1.18 - 1.42) 
 
1.31 (1.19 - 1.45) 
 
1.11 (1.06 - 1.16) 
 
0.98 (0.90 - 1.07) 
Age: 80-84 * male 0.91 (0.84 - 0.98) 
 
1.04 (0.73 - 1.47) 
 
1.14 (1.06 - 1.23) 
 
1.19 (1.06 - 1.35) 
 
1.08 (1.03 - 1.12) 
 
1.10 (1.02 - 1.20) 
Age: 85+ * male 0.96 (0.89 - 1.02) 
 
1.01 (0.41 - 2.50) 
 
1.18 (1.12 - 1.25) 
 
1.35 (1.15 - 1.59) 
 
1.10 (1.07 - 1.14) 
 
1.12 (1.04 - 1.20) 
Elixhauser: 0 comorbidities 0.67 (0.63 - 0.71) 
 
0.60 (0.49 - 0.73) 
 
0.68 (0.64 - 0.72) 
 
0.52 (0.49 - 0.57) 
 
0.63 (0.61 - 0.66) 
 
0.66 (0.62 - 0.71) 
Elixhauser: 1 comorbidity 0.71 (0.68 - 0.75) 
 
0.64 (0.55 - 0.73) 
 
0.75 (0.72 - 0.79) 
 
0.62 (0.58 - 0.67) 
 
0.77 (0.74 - 0.79) 
 
0.73 (0.69 - 0.77) 
Elixhauser: 2-3 comorbidities 0.81 (0.77 - 0.84) 
 
0.73 (0.67 - 0.80) 
 
0.86 (0.83 - 0.90) 
 
0.77 (0.72 - 0.82) 
 
0.86 (0.84 - 0.88) 
 
0.83 (0.79 - 0.87) 
Elixhauser: 4+ comorbidities (excluded) 1.00 (1.00 - 1.00) 
 
1.00 (1.00 - 1.00) 
 
1.00 (1.00 - 1.00) 
 
1.00 (1.00 - 1.00) 
 
1.00 (1.00 - 1.00) 
 
1.00 (1.00 - 1.00) 
Emergency admission in last year (yes/no) 1.72 (1.66 - 1.78) 
 
1.42 (1.31 - 1.54) 
 
1.45 (1.40 - 1.50) 
 
1.45 (1.36 - 1.54) 
 
1.71 (1.68 - 1.75) 
 
1.54 (1.48 - 1.61) 
Socio-economic status: 1st quintile 0.92 (0.88 - 0.97) 
 
0.87 (0.78 - 0.98) 
 
0.78 (0.74 - 0.82) 
 
0.88 (0.82 - 0.95) 
 
0.85 (0.83 - 0.88) 
 
0.93 (0.88 - 0.98) 
Socio-economic status: 2nd quintile 0.92 (0.88 - 0.97) 
 
0.81 (0.71 - 0.92) 
 
0.86 (0.81 - 0.90) 
 
0.90 (0.84 - 0.96) 
 
0.87 (0.85 - 0.90) 
 
0.94 (0.89 - 1.00) 
Socio-economic status: 3rd quintile 0.94 (0.90 - 0.99) 
 
0.92 (0.80 - 1.05) 
 
0.87 (0.83 - 0.91) 
 
0.88 (0.81 - 0.95) 
 
0.90 (0.87 - 0.93) 
 
0.96 (0.91 - 1.02) 
Socio-economic status: 4th quintile 0.99 (0.94 - 1.03) 
 
0.79 (0.70 - 0.89) 
 
0.92 (0.87 - 0.96) 
 
1.03 (0.96 - 1.10) 
 
0.95 (0.93 - 0.98) 
 
0.99 (0.94 - 1.05) 
Socio-economic status: 5th quintile (excluded) 1.00 (1.00 - 1.00) 
 
1.00 (1.00 - 1.00) 
 
1.00 (1.00 - 1.00) 
 
1.00 (1.00 - 1.00) 
 
1.00 (1.00 - 1.00) 
 
1.00 (1.00 - 1.00) 
Financial year 2009/10 1.01 (0.98 - 1.05) 
 
1.05 (0.96 - 1.16) 
 
0.98 (0.94 - 1.02) 
 
1.15 (1.09 - 1.21) 
 
0.94 (0.92 - 0.97) 
 
0.93 (0.89 - 0.97) 
Financial year 2010/11 1.01 (0.97 - 1.04) 
 
1.04 (0.94 - 1.15) 
 
0.96 (0.92 - 0.99) 
 
1.08 (1.02 - 1.14) 
 
0.98 (0.96 - 1.01) 
 
0.93 (0.90 - 0.97) 
Financial year 2011/12 (excluded) 1.00 (1.00 - 1.00)  1.00 (1.00 - 1.00)  1.00 (1.00 - 1.00)  1.00 (1.00 - 1.00)  1.00 (1.00 - 1.00)  1.00 (1.00 - 1.00) 
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Appendix 3: Odds ratios (ORs) and 95% confidence intervals (CIs) ʹ 30-day mortality 
  AMI   CABG   Hip fracture   Hip replacement   Pneumonia   Stroke 
Variable OR 95%CI   OR 95%CI   OR 95%CI   OR 95%CI   OR 95%CI   OR 95%CI 
Age: <60 0.12 (0.10 - 0.14)   0.12 (0.02 - 0.71)   0.13 (0.10 - 0.18)   0.09 (0.04 - 0.20)   0.14 (0.13 - 0.15)   0.11 (0.09 - 0.12) 
Age: 60-64 0.20 (0.17 - 0.23) 
 
0.13 (0.02 - 0.82) 
 
0.21 (0.16 - 0.27) 
 
0.08 (0.03 - 0.20) 
 
0.28 (0.26 - 0.30) 
 
0.17 (0.15 - 0.20) 
Age: 65-69 0.22 (0.19 - 0.26) 
 
0.22 (0.04 - 1.08) 
 
0.22 (0.18 - 0.27) 
 
0.09 (0.04 - 0.20) 
 
0.31 (0.29 - 0.33) 
 
0.21 (0.18 - 0.23) 
Age: 70-74 0.32 (0.28 - 0.35) 
 
0.28 (0.06 - 1.30) 
 
0.27 (0.23 - 0.31) 
 
0.25 (0.15 - 0.42) 
 
0.39 (0.37 - 0.40) 
 
0.26 (0.24 - 0.29) 
Age: 75-79 0.43 (0.40 - 0.47) 
 
0.52 (0.12 - 2.34) 
 
0.38 (0.35 - 0.42) 
 
0.25 (0.15 - 0.42) 
 
0.48 (0.47 - 0.50) 
 
0.35 (0.33 - 0.38) 
Age: 80-84 0.63 (0.58 - 0.68) 
 
0.85 (0.18 - 3.97) 
 
0.54 (0.50 - 0.57) 
 
0.33 (0.20 - 0.56) 
 
0.63 (0.61 - 0.65) 
 
0.51 (0.49 - 0.54) 
Age: 85+ (excluded) 1.00 (1.00 - 1.00) 
 
1.00 (1.00 - 1.00) 
 
1.00 (1.00 - 1.00) 
 
1.00 (1.00 - 1.00) 
 
1.00 (1.00 - 1.00) 
 
1.00 (1.00 - 1.00) 
Age: <60 * male 0.93 (0.78 - 1.10) 
 
0.33 (0.10 - 1.09) 
 
0.90 (0.58 - 1.38) 
 
1.00 (0.36 - 2.76) 
 
1.23 (1.16 - 1.31) 
 
1.09 (0.92 - 1.29) 
Age: 60-64 * male 0.94 (0.78 - 1.14) 
 
1.18 (0.35 - 3.91) 
 
1.11 (0.75 - 1.66) 
 
2.93 (1.02 - 8.42) 
 
1.21 (1.13 - 1.31) 
 
0.87 (0.72 - 1.06) 
Age: 65-69 * male 1.01 (0.86 - 1.19) 
 
0.94 (0.42 - 2.13) 
 
2.06 (1.57 - 2.70) 
 
3.79 (1.68 - 8.56) 
 
1.29 (1.21 - 1.37) 
 
0.97 (0.84 - 1.12) 
Age: 70-74 * male 1.03 (0.90 - 1.16) 
 
0.85 (0.43 - 1.68) 
 
1.80 (1.47 - 2.22) 
 
1.34 (0.76 - 2.37) 
 
1.19 (1.13 - 1.25) 
 
0.90 (0.80 - 1.01) 
Age: 75-79 * male 1.02 (0.92 - 1.13) 
 
0.83 (0.49 - 1.41) 
 
1.73 (1.51 - 1.98) 
 
2.98 (1.83 - 4.85) 
 
1.14 (1.09 - 1.19) 
 
0.87 (0.79 - 0.95) 
Age: 80-84 * male 0.96 (0.88 - 1.05) 
 
0.49 (0.23 - 1.02) 
 
1.89 (1.72 - 2.07) 
 
2.95 (1.75 - 4.98) 
 
1.09 (1.05 - 1.13) 
 
0.87 (0.81 - 0.94) 
Age: 85+ * male 1.00 (0.93 - 1.06) 
 
0.39 (0.05 - 2.82) 
 
1.71 (1.62 - 1.80) 
 
2.29 (1.44 - 3.64) 
 
1.03 (1.00 - 1.05) 
 
0.78 (0.74 - 0.82) 
Elixhauser: 0 comorbidities 0.39 (0.36 - 0.43) 
 
0.15 (0.04 - 0.61) 
 
0.29 (0.27 - 0.32) 
 
0.17 (0.11 - 0.26) 
 
0.39 (0.38 - 0.41) 
 
0.58 (0.54 - 0.62) 
Elixhauser: 1 comorbidity 0.46 (0.43 - 0.49) 
 
0.50 (0.29 - 0.85) 
 
0.37 (0.35 - 0.39) 
 
0.28 (0.20 - 0.39) 
 
0.55 (0.53 - 0.57) 
 
0.63 (0.60 - 0.67) 
Elixhauser: 2-3 comorbidities 0.66 (0.63 - 0.70) 
 
0.34 (0.23 - 0.48) 
 
0.56 (0.53 - 0.59) 
 
0.34 (0.26 - 0.46) 
 
0.74 (0.72 - 0.75) 
 
0.77 (0.74 - 0.80) 
Elixhauser: 4+ comorbidities (excluded) 1.00 (1.00 - 1.00) 
 
1.00 (1.00 - 1.00) 
 
1.00 (1.00 - 1.00) 
 
1.00 (1.00 - 1.00) 
 
1.00 (1.00 - 1.00) 
 
1.00 (1.00 - 1.00) 
Emergency admission in last year (yes/no) 0.95 (0.90 - 0.99) 
 
1.44 (1.11 - 1.88) 
 
1.05 (1.00 - 1.10) 
 
1.40 (1.05 - 1.86) 
 
1.10 (1.08 - 1.12) 
 
1.29 (1.24 - 1.34) 
Socio-economic status: 1st quintile 0.95 (0.89 - 1.02) 
 
0.83 (0.56 - 1.21) 
 
0.87 (0.81 - 0.92) 
 
0.51 (0.36 - 0.72) 
 
1.03 (1.00 - 1.06) 
 
0.94 (0.89 - 0.99) 
Socio-economic status: 2nd quintile 0.95 (0.89 - 1.02) 
 
0.80 (0.53 - 1.23) 
 
0.91 (0.85 - 0.97) 
 
0.70 (0.51 - 0.97) 
 
1.05 (1.03 - 1.08) 
 
1.01 (0.96 - 1.07) 
Socio-economic status: 3rd quintile 0.99 (0.93 - 1.06) 
 
0.89 (0.58 - 1.36) 
 
0.94 (0.88 - 1.00) 
 
0.64 (0.44 - 0.93) 
 
1.07 (1.04 - 1.09) 
 
1.02 (0.97 - 1.08) 
Socio-economic status: 4th quintile 1.02 (0.96 - 1.09) 
 
0.63 (0.41 - 0.98) 
 
0.93 (0.87 - 0.99) 
 
0.57 (0.40 - 0.80) 
 
1.05 (1.02 - 1.07) 
 
1.01 (0.96 - 1.06) 
Socio-economic status: 5th quintile (excluded) 1.00 (1.00 - 1.00) 
 
1.00 (1.00 - 1.00) 
 
1.00 (1.00 - 1.00) 
 
1.00 (1.00 - 1.00) 
 
1.00 (1.00 - 1.00) 
 
1.00 (1.00 - 1.00) 
Financial year 2009/10 1.17 (1.12 - 1.23) 
 
0.97 (0.71 - 1.34) 
 
1.12 (1.06 - 1.17) 
 
1.46 (1.11 - 1.92) 
 
1.11 (1.09 - 1.13) 
 
1.14 (1.10 - 1.19) 
Financial year 2010/11 1.11 (1.06 - 1.16) 
 
0.86 (0.62 - 1.19) 
 
1.04 (0.99 - 1.10) 
 
1.14 (0.85 - 1.51) 
 
1.02 (1.00 - 1.04) 
 
1.04 (1.00 - 1.09) 
Financial year 2011/12 (excluded) 1.00 (1.00 - 1.00)  1.00 (1.00 - 1.00)  1.00 (1.00 - 1.00)  1.00 (1.00 - 1.00)  1.00 (1.00 - 1.00)  1.00 (1.00 - 1.00) 
 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
Appendix 4: Incidence rate ratios (IRRs) and 95% confidence intervals (CIs) - Length of stay 
  AMI   CABG   Hip fracture   Hip replacement   Pneumonia   Stroke 
Variable IRR 95%CI   IRR 95%CI   IRR 95%CI   IRR 95%CI   IRR 95%CI   IRR 95%CI 
Age: <25 0.82 (0.50 - 1.35)         0.37 (0.29 - 0.46)   0.53 (0.49 - 0.57)   0.47 (0.45 - 0.49)   0.55 (0.43 - 0.70) 
Age: 25-29 0.85 (0.61 - 1.18) 
    
0.36 (0.29 - 0.45) 
 
0.48 (0.44 - 0.51) 
 
0.43 (0.41 - 0.45) 
 
0.67 (0.53 - 0.85) 
Age: 30-34 0.74 (0.61 - 0.89) 
    
0.37 (0.30 - 0.45) 
 
0.51 (0.48 - 0.54) 
 
0.46 (0.44 - 0.48) 
 
0.61 (0.51 - 0.73) 
Age: 35-39 0.67 (0.60 - 0.74) 
    
0.36 (0.30 - 0.42) 
 
0.50 (0.48 - 0.53) 
 
0.47 (0.45 - 0.49) 
 
0.61 (0.53 - 0.70) 
Age: 40-44 0.69 (0.65 - 0.74) 
 
0.58 (0.47 - 0.72)
 
0.38 (0.34 - 0.43) 
 
0.48 (0.46 - 0.50) 
 
0.53 (0.51 - 0.55) 
 
0.63 (0.58 - 0.70) 
Age: 45-49 0.70 (0.67 - 0.74) 
 
0.54 (0.45 - 0.64) 
 
0.41 (0.38 - 0.45) 
 
0.48 (0.47 - 0.50) 
 
0.57 (0.55 - 0.59) 
 
0.61 (0.57 - 0.66) 
Age: 50-54 0.72 (0.69 - 0.75) 
 
0.56 (0.48 - 0.66) 
 
0.44 (0.42 - 0.47) 
 
0.49 (0.48 - 0.50) 
 
0.60 (0.58 - 0.62) 
 
0.56 (0.53 - 0.60) 
Age: 55-59 0.72 (0.69 - 0.75) 
 
0.59 (0.50 - 0.69) 
 
0.50 (0.48 - 0.52) 
 
0.49 (0.49 - 0.50) 
 
0.62 (0.60 - 0.64) 
 
0.56 (0.53 - 0.60) 
Age: 60-64 0.77 (0.75 - 0.80) 
 
0.59 (0.51 - 0.69) 
 
0.53 (0.51 - 0.55) 
 
0.51 (0.50 - 0.52) 
 
0.65 (0.64 - 0.67) 
 
0.65 (0.62 - 0.68) 
Age: 65-69 0.82 (0.80 - 0.84) 
 
0.63 (0.55 - 0.74) 
 
0.59 (0.58 - 0.61) 
 
0.53 (0.52 - 0.54) 
 
0.70 (0.69 - 0.72) 
 
0.69 (0.67 - 0.72) 
Age: 70-74 0.87 (0.85 - 0.90) 
 
0.68 (0.58 - 0.79) 
 
0.68 (0.67 - 0.70) 
 
0.58 (0.57 - 0.59) 
 
0.76 (0.74 - 0.77) 
 
0.79 (0.77 - 0.82) 
Age: 75-79 0.94 (0.92 - 0.96) 
 
0.80 (0.69 - 0.93) 
 
0.79 (0.78 - 0.80) 
 
0.66 (0.65 - 0.67) 
 
0.83 (0.82 - 0.85) 
 
0.88 (0.86 - 0.91) 
Age: 80-84 0.99 (0.96 - 1.01) 
 
0.81 (0.70 - 0.95) 
 
0.90 (0.88 - 0.91) 
 
0.79 (0.78 - 0.81) 
 
0.91 (0.90 - 0.93) 
 
0.97 (0.94 - 0.99) 
Age: 85+ (excluded) 1.00 (1.00 - 1.00) 
 
1.00 (1.00 - 1.00) 
 
1.00 (1.00 - 1.00) 
 
1.00 (1.00 - 1.00) 
 
1.00 (1.00 - 1.00) 
 
1.00 (1.00 - 1.00) 
Age: <25 * male 0.81 (0.46 - 1.41) 
    
1.15 (0.89 - 1.50) 
 
0.86 (0.77 - 0.97) 
 
1.11 (1.03 - 1.18) 
 
1.28 (0.88 - 1.85) 
Age: 25-29 * male 0.80 (0.55 - 1.16) 
    
1.05 (0.81 - 1.35) 
 
0.88 (0.79 - 0.98) 
 
1.16 (1.08 - 1.25) 
 
1.07 (0.78 - 1.48) 
Age: 30-34 * male 0.92 (0.75 - 1.14) 
    
1.01 (0.80 - 1.28) 
 
0.86 (0.79 - 0.93) 
 
1.09 (1.03 - 1.16) 
 
1.09 (0.85 - 1.40) 
Age: 35-39 * male 1.03 (0.92 - 1.16) 
    
0.98 (0.81 - 1.18) 
 
0.88 (0.83 - 0.93) 
 
1.15 (1.09 - 1.22) 
 
1.04 (0.86 - 1.25) 
Age: 40-44 * male 0.98 (0.91 - 1.05) 
 
0.96 (0.81 - 1.14)
 
0.99 (0.86 - 1.14) 
 
0.89 (0.85 - 0.93) 
 
1.06 (1.01 - 1.11) 
 
1.01 (0.89 - 1.14) 
Age: 45-49 * male 1.00 (0.95 - 1.05) 
 
0.97 (0.87 - 1.08) 
 
1.07 (0.96 - 1.18) 
 
0.91 (0.88 - 0.94) 
 
1.05 (1.01 - 1.10) 
 
0.98 (0.89 - 1.08) 
Age: 50-54 * male 1.01 (0.96 - 1.05) 
 
0.97 (0.90 - 1.04) 
 
1.09 (1.00 - 1.18) 
 
0.89 (0.87 - 0.92) 
 
1.02 (0.98 - 1.07) 
 
1.06 (0.97 - 1.14) 
Age: 55-59 * male 1.04 (1.00 - 1.08) 
 
0.94 (0.88 - 1.00) 
 
1.09 (1.02 - 1.17) 
 
0.91 (0.89 - 0.92) 
 
1.02 (0.98 - 1.05) 
 
1.05 (0.97 - 1.12) 
Age: 60-64 * male 1.01 (0.98 - 1.04) 
 
0.96 (0.92 - 1.01) 
 
1.17 (1.11 - 1.23) 
 
0.91 (0.90 - 0.93) 
 
1.02 (0.99 - 1.06) 
 
0.95 (0.89 - 1.00) 
Age: 65-69 * male 1.01 (0.98 - 1.04) 
 
0.94 (0.90 - 0.98) 
 
1.16 (1.12 - 1.21) 
 
0.92 (0.91 - 0.93) 
 
0.97 (0.94 - 0.99) 
 
0.96 (0.92 - 1.01) 
Age: 70-74 * male 1.02 (0.99 - 1.05) 
 
0.94 (0.91 - 0.98) 
 
1.13 (1.09 - 1.16) 
 
0.92 (0.90 - 0.93) 
 
0.95 (0.93 - 0.97) 
 
0.93 (0.89 - 0.97) 
Age: 75-79 * male 0.97 (0.95 - 1.00) 
 
0.88 (0.84 - 0.91) 
 
1.11 (1.08 - 1.14) 
 
0.92 (0.91 - 0.93) 
 
0.95 (0.93 - 0.97) 
 
0.90 (0.86 - 0.93) 
Age: 80-84 * male 0.97 (0.95 - 0.99) 
 
1.01 (0.95 - 1.07) 
 
1.07 (1.05 - 1.09) 
 
0.93 (0.91 - 0.95) 
 
0.95 (0.93 - 0.97) 
 
0.90 (0.87 - 0.93) 
Age: 85+ * male 0.96 (0.94 - 0.98) 
 
1.03 (0.87 - 1.22) 
 
1.03 (1.02 - 1.05) 
 
0.97 (0.94 - 0.99) 
 
0.96 (0.95 - 0.97) 
 
0.96 (0.94 - 0.99) 
Elixhauser: 0 comorbidities 0.50 (0.50 - 0.51) 
 
0.74 (0.72 - 0.77) 
 
0.62 (0.61 - 0.63) 
 
0.72 (0.71 - 0.72) 
 
0.50 (0.49 - 0.50) 
 
0.46 (0.45 - 0.47) 
Elixhauser: 1 comorbidity 0.57 (0.56 - 0.58) 
 
0.77 (0.75 - 0.79) 
 
0.74 (0.73 - 0.75) 
 
0.76 (0.75 - 0.77) 
 
0.65 (0.64 - 0.66) 
 
0.57 (0.56 - 0.59) 
Elixhauser: 2-3 comorbidities 0.71 (0.70 - 0.72) 
 
0.82 (0.81 - 0.83) 
 
0.85 (0.84 - 0.86) 
 
0.84 (0.83 - 0.85) 
 
0.81 (0.80 - 0.82) 
 
0.78 (0.77 - 0.80) 
Elixhauser: 4+ comorbidities (excluded) 1.00 (1.00 - 1.00) 
 
1.00 (1.00 - 1.00) 
 
1.00 (1.00 - 1.00) 
 
1.00 (1.00 - 1.00) 
 
1.00 (1.00 - 1.00) 
 
1.00 (1.00 - 1.00) 
Emergency admission in last year (yes/no) 0.86 (0.85 - 0.87) 
 
1.06 (1.04 - 1.07) 
 
1.01 (1.00 - 1.02) 
 
1.17 (1.16 - 1.18) 
 
0.98 (0.97 - 0.98) 
 
0.85 (0.83 - 0.86) 
Socio-economic status: 1st quintile 0.98 (0.96 - 0.99) 
 
0.93 (0.91 - 0.95) 
 
0.93 (0.92 - 0.94) 
 
0.94 (0.93 - 0.95) 
 
0.99 (0.98 - 1.00) 
 
0.95 (0.93 - 0.97) 
Socio-economic status: 2nd quintile 0.98 (0.97 - 1.00) 
 
0.95 (0.93 - 0.97) 
 
0.95 (0.94 - 0.97) 
 
0.95 (0.94 - 0.96) 
 
0.99 (0.98 - 1.00) 
 
0.95 (0.93 - 0.98) 
Socio-economic status: 3rd quintile 0.99 (0.98 - 1.01) 
 
0.97 (0.95 - 0.99) 
 
0.96 (0.95 - 0.98) 
 
0.96 (0.95 - 0.97) 
 
1.00 (0.98 - 1.01) 
 
0.98 (0.96 - 1.01) 
Socio-economic status: 4th quintile 0.99 (0.98 - 1.01) 
 
0.98 (0.96 - 1.01) 
 
0.99 (0.97 - 1.00) 
 
0.98 (0.97 - 0.99) 
 
1.00 (0.99 - 1.01) 
 
0.99 (0.97 - 1.01) 
Socio-economic status: 5th quintile (excluded) 1.00 (1.00 - 1.00) 
 
1.00 (1.00 - 1.00) 
 
1.00 (1.00 - 1.00) 
 
1.00 (1.00 - 1.00) 
 
1.00 (1.00 - 1.00) 
 
1.00 (1.00 - 1.00) 
Financial year 2009/10 1.08 (1.06 - 1.09) 
 
1.01 (1.00 - 1.03) 
 
1.15 (1.13 - 1.16) 
 
1.16 (1.16 - 1.17) 
 
1.03 (1.02 - 1.04) 
 
1.20 (1.18 - 1.23) 
Financial year 2010/11 1.03 (1.02 - 1.04) 
 
1.00 (0.99 - 1.02) 
 
1.08 (1.07 - 1.09) 
 
1.07 (1.07 - 1.08) 
 
1.00 (0.99 - 1.01) 
 
1.10 (1.08 - 1.12) 
Financial year 2011/12 (excluded) 1.00 (1.00 - 1.00)  1.00 (1.00 - 1.00)  1.00 (1.00 - 1.00)  1.00 (1.00 - 1.00)  1.00 (1.00 - 1.00)  1.00 (1.00 - 1.00) 
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Appendix 5: Proportion of variance explained by observed patient characteristics (Pseudo-R
2
) 
Condition 
Pseudo-R
2
 
28-day emergency 
readmission 
30-day mortality Length of stay 
AMI 21.0% 4.4% 11.7% 
CABG 26.9% 3.3% 13.7% 
Hip fracture 18.5% 3.5% 12.7% 
Hip 
replacement 26.3% 4.3% 22.8% 
Pneumonia 16.7% 4.4% 8.0% 
Stroke 17.1% 2.7% 5.7% 
Notes: McKelvey-Zavoina Pseudo-R
2
 statistics is defined at the latent scale and is 
calculated as the ratio of the variance of the linear predictor to the sum of all 
variance components and the variance of the linear predictor. 
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Figures and tables 
Figure 1: Proportion of variation attributable to consultants and hospitals; case-mix adjusted 
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Table 1: Descriptive statistics of patient sample (April 2010 to February 2013) 
  AMI  
CABG 
 
Hip fracture 
 
Hip replacement 
 
Pneumonia 
 
Stroke 
 
Total 
  Mean SD   Mean SD   Mean SD   Mean SD   Mean SD   Mean SD   Mean SD 
Patient level 
                    
28-day emergency readmission (yes/no) 0.15 0.36 
 
0.12 0.32 
 
0.12 0.32 
 
0.05 0.22 
 
0.15 0.35 
 
0.10 0.30 
 
0.12 0.33 
30-day mortality (yes/no) 0.07 0.26 
 
0.01 0.09 
 
0.06 0.23 
 
0.00 0.03 
 
0.19 0.40 
 
0.11 0.32 
 
0.11 0.31 
Length of stay (in days) 7.74 9.09 
 
9.08 6.67 
 
23.51 21.34 
 
5.32 3.99 
 
10.62 13.07 
 
19.65 26.17 
 
12.52 16.83 
Patient age (in years) 69.75 14.14 
 
66.07 9.35 
 
81.00 11.42 
 
67.96 11.51 
 
73.80 16.63 
 
75.37 13.20 
 
73.42 14.81 
Male (yes/no) 0.65 0.48 
 
0.83 0.37 
 
0.27 0.44 
 
0.40 0.49 
 
0.51 0.50 
 
0.49 0.50 
 
0.48 0.50 
Elixhauser: 0 comorbidities 0.15 0.36 
 
0.06 0.23 
 
0.15 0.36 
 
0.32 0.47 
 
0.10 0.30 
 
0.11 0.31 
 
0.15 0.36 
Elixhauser: 1 comorbidity 0.21 0.41 
 
0.11 0.32 
 
0.22 0.41 
 
0.28 0.45 
 
0.14 0.34 
 
0.20 0.40 
 
0.19 0.39 
Elixhauser: 2-3 comorbidities 0.33 0.47 
 
0.35 0.48 
 
0.35 0.48 
 
0.29 0.45 
 
0.29 0.45 
 
0.37 0.48 
 
0.32 0.46 
Elixhauser: 4+ comorbidities 0.31 0.46 
 
0.48 0.50 
 
0.28 0.45 
 
0.11 0.31 
 
0.48 0.50 
 
0.32 0.47 
 
0.34 0.47 
Emergency admission in last year (yes/no) 0.26 0.44 
 
0.38 0.49 
 
0.33 0.47 
 
0.09 0.29 
 
0.51 0.50 
 
0.31 0.46 
 
0.35 0.48 
Number of patients 138,044 
 
24,505 
 
156,145 
 
170,678 
 
405,671 
 
144,114 
 
1,039,157 
                     
Consultant level 
                    
Number of consultants 1,746 
  
212 
  
1,735 
  
1,325 
  
3,760 
  
1,214 
  
9,992 
 
Case-load: Median 56 
  
104 
  
86 
  
95 
  
83 
  
55 
  
78 
 
Case-load: 25th percentile 39 
  
72 
  
60 
  
56 
  
52 
  
38 
  
47 
 
Case-load: 75th percentile 94 
  
158 
  
112 
  
167 
  
131 
  
149 
  
125 
 
                     
Hospital level 
                    
Number of hospitals 148 
  
30 
  
148 
  
229 
  
152 
  
144 
  
851 
 Case-load: Median 787 
  
734 
  
1000 
  
649 
  
2471 
  
946 
  
946 
 Case-load: 25th percentile 505 
  
616 
  
705.5 
  
224 
  
1794 
  
632.5 
  
570 
 Case-load: 75th percentile 1214.5     953     1337.5     985     3350     1348.5     1571   
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Table 2: Reliability of consultant performance estimates 
  Estimated variance components   
Case-load 
(median)     Case-load required   
% Consultants 
with sufficient 
case-load over 35 
months 
Condition ߪଶ ߬ଶ ߱ଶ VPC R   R=0.7 R=0.9   R=0.7 R=0.9 
28-day emergency readmission 
AMI 0.23955 0.00102 0.00095 0.4% 56 0.19 
 
552 2131 
 
0.0% 0.0% 
CABG 0.21058 0.00178 0.00065 0.8% 104 0.47 
 
277 1068 
 
0.5% 0.0% 
Hip fracture 0.23855 0.00180 0.00144 0.7% 86 0.39 
 
312 1203 
 
0.3% 0.1% 
Hip replacement 0.20456 0.00527 0.00348 2.5% 95 0.71 
 
92 355 
 
51.0% 3.8% 
Pneumonia 0.24823 0.00103 0.00060 0.4% 83 0.26 
 
563 2171 
 
0.7% 0.0% 
Stroke 0.24581 0.00188 0.00107 0.8% 55 0.29 
 
307 1183 
 
8.9% 0.0% 
             30-day mortality 
AMI 0.143812 0.002077 0.000857 1.4% 56 0.45 
 
163 627 
 
10.0% 0.0% 
CABG 0.065208 0.000578 0.000289 0.9% 104 0.48 
 
264 1020 
 
0.5% 0.0% 
Hip fracture 0.186773 0.002375 0.001295 1.2% 86 0.52 
 
185 713 
 
2.1% 0.1% 
Pneumonia 0.204589 0.002588 0.001311 1.2% 83 0.51 
 
186 716 
 
10.5% 0.4% 
Stroke 0.174487 0.001901 0.000806 1.1% 55 0.37 
 
215 830 
 
16.6% 0.2% 
             Length of stay 
AMI 118.748 8.623 5.987 6.5% 56 0.79 
 
34 130 
 
89.6% 14.5% 
CABG 64.090 3.648 2.417 5.2% 104 0.85 
 
43 164 
 
93.4% 19.3% 
Hip fracture 2270.457 77.193 51.934 3.2% 86 0.74 
 
70 271 
 
65.6% 0.4% 
Hip replacement 30.123 4.921 3.855 12.7% 95 0.93 
 
16 62 
 
100.0% 70.0% 
Pneumonia 2354.658 50.766 13.211 2.1% 83 0.64 
 
109 420 
 
35.1% 1.5% 
Stroke 28799.816 453.625 105.254 1.5% 55 0.46   149 573   25.0% 1.6% 
Notes: R = Reliability; VPC = Variance partition coefficient at consultant level. Median case-load is measured over the period April 2010 to February 2013. Variation in 
mortality after hip replacement at consultant level could not be differentiated from that at hospital level and the corresponding statistics are therefore not recorded.  
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Table 3: Reliability of hospital performance estimates 
  Estimated variance components   
Case-load 
(median) 
    Case-load required   
% Consultants 
with sufficient 
case-load over 35 
months 
Condition ߪଶ ߬ଶ ߱ଶ VPC* R   R=0.7 R=0.9   R=0.7 R=0.9 
28-day emergency readmission 
AMI 0.23955 0.00102 0.00095 0.8% 787 0.87 
 
284 1095 
 
89.9% 29.1% 
CABG 0.21058 0.00178 0.00065 1.1% 734 0.89 
 
202 779 
 
100.0% 46.7% 
Hip fracture 0.23855 0.00180 0.00144 1.3% 1000 0.93 
 
172 664 
 
96.6% 79.1% 
Hip replacement 0.20456 0.00527 0.00348 4.1% 649 0.97 
 
55 210 
 
97.8% 77.3% 
Pneumonia 0.24823 0.00103 0.00060 0.7% 2471 0.94 
 
356 1371 
 
98.7% 86.2% 
Stroke 0.24581 0.00188 0.00107 1.2% 946 0.92 
 
194 750 
 
91.7% 63.9% 
             30-day mortality 
AMI 0.143812 0.002077 0.000857 2.0% 787 0.94 
 
114 441 
 
94.6% 80.4% 
CABG 0.065208 0.000578 0.000289 1.3% 734 0.91 
 
176 677 
 
100.0% 56.7% 
Hip fracture 0.186773 0.002375 0.001295 1.9% 1000 0.95 
 
119 458 
 
98.6% 87.8% 
Pneumonia 0.204589 0.002588 0.001311 1.9% 2471 0.98 
 
122 472 
 
99.3% 97.4% 
Stroke 0.174487 0.001901 0.000806 1.5% 946 0.94 
 
150 580 
 
92.4% 77.8% 
             Length of stay 
AMI 118.748 8.623 5.987 11.0% 787 0.99 
 
19 73 
 
100.0% 95.3% 
CABG 64.090 3.648 2.417 8.6% 734 0.99 
 
25 95 
 
100.0% 100.0% 
Hip fracture 2270.457 77.193 51.934 5.4% 1000 0.98 
 
41 158 
 
99.3% 96.6% 
Hip replacement 30.123 4.921 3.855 22.6% 649 0.99 
 
8 31 
 
100.0% 99.6% 
Pneumonia 2354.658 50.766 13.211 2.6% 2471 0.99 
 
86 331 
 
100.0% 98.7% 
Stroke 28799.816 453.625 105.254 1.9% 946 0.95   120 464   93.1% 80.6% 
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Notes: R = Reliability; VPC* = Sum of variance partition coefficients at consultant and hospital levels. Median case-load is measured over the period April 2010 to February 
2013. Variation in mortality after hip replacement at consultant level could not be differentiated from that at hospital level and the corresponding statistics are therefore 
not recorded.   
 
